NRAS |
P01111
|
NRAS proto-oncogene, GTPase
|
Enzyme modulator
|
0.49 |
0.390 |
0.808 |
PDGFRA |
P16234
|
platelet derived growth factor receptor alpha
|
Kinase
|
1.00 |
0.415 |
0.808 |
MAP2K7 |
O14733
|
mitogen-activated protein kinase kinase 7
|
Kinase
|
1.00 |
0.419 |
0.808 |
TMED7 |
Q86XR7 Q9Y3B3
|
transmembrane p24 trafficking protein 7
|
Transporter
|
0.48 |
0.436 |
0.808 |
TET2 |
Q6N021
|
tet methylcytosine dioxygenase 2
|
|
4.3E-54 |
0.458 |
0.808 |
ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
MIR150 |
|
microRNA 150
|
|
|
0.455 |
0.808 |
MIR223 |
|
microRNA 223
|
|
|
0.433 |
0.808 |
CBL |
P22681
|
Cbl proto-oncogene
|
Enzyme
|
6.1E-04 |
0.527 |
0.769 |
CCR7 |
P32248
|
C-C motif chemokine receptor 7
|
G-protein coupled receptor
|
5.8E-02 |
0.443 |
0.769 |
FANCB |
Q8NB91
|
FA complementation group B
|
|
1.00 |
0.468 |
0.769 |
IFI27 |
P40305
|
interferon alpha inducible protein 27
|
|
1.1E-02 |
0.437 |
0.769 |
ZNRD2 |
O60232
|
zinc ribbon domain containing 2
|
|
1.8E-07 |
0.443 |
0.769 |
DCTN6 |
O00399
|
dynactin subunit 6
|
Cellular structure
|
5.6E-02 |
0.442 |
0.769 |
TICAM2 |
Q86XR7 Q9Y3B3
|
toll like receptor adaptor molecule 2
|
|
2.6E-03 |
0.438 |
0.769 |
TMED7-TICAM2 |
Q86XR7 Q9Y3B3
|
TMED7-TICAM2 readthrough
|
|
2.6E-03 |
0.438 |
0.769 |
H3P23 |
|
H3 histone pseudogene 23
|
|
|
0.443 |
0.769 |
ETV6 |
P41212
|
ETS variant transcription factor 6
|
Transcription factor
|
0.97 |
0.477 |
0.731 |
MECOM |
Q03112
|
MDS1 and EVI1 complex locus
|
|
1.00 |
0.513 |
0.731 |
IL3 |
P08700
|
interleukin 3
|
|
2.6E-09 |
0.489 |
0.731 |
SRSF2 |
Q01130
|
serine and arginine rich splicing factor 2
|
Nucleic acid binding
|
0.48 |
0.561 |
0.731 |
SF3B1 |
O75533
|
splicing factor 3b subunit 1
|
Nucleic acid binding
|
1.00 |
0.511 |
0.731 |
MYB |
P10242
|
MYB proto-oncogene, transcription factor
|
|
0.82 |
0.490 |
0.692 |
THPO |
P40225
|
thrombopoietin
|
|
0.20 |
0.513 |
0.692 |
FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |